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Children with inflammatory bowel disease (IBD) have increased risk for venous thromboembolism 
(VTE). We sought to determine incidence and risk factors for postoperative VTE in a multicenter cohort 
of pediatric patients undergoing colorectal resection for IBD. 
Methods 
Retrospective review of children ≤18yrs who underwent colorectal resection for IBD from 2010-2016 
was performed at four children’s hospitals. Primary outcome was VTE that occurred between surgery and 
last follow-up. Factors associated with VTE were determined using univariable and multivariable 
analyses. 
Results 
Two-hundred-and-seventy-six patients were included with median age 15yrs [13,17]. Forty-two children 
(15%) received perioperative VTE chemoprophylaxis, and 88 (32%) received mechanical prophylaxis. 
DVT occurred in 12 patients (4.3%) at a median of 14 days postoperatively [8,147]. Most were 
portomesenteric (n=9, 75%) with the remaining catheter-associated DVTs in extremities (n=3, 25%). 
There was no association with chemoprophylaxis (p>0.99). On Cox regression, emergent procedure [HR 
18.8, 95%CI: 3.18-111], perioperative plasma transfusion [HR 25.1, 95%CI: 2.4-259], and postoperative 
infectious complication [HR 10.5, 95%CI: 2.63-41.8] remained predictive of DVT. 
Conclusion 
Less than 5% of pediatric IBD patients developed postoperative VTE. Chemoprophylaxis was not 
protective but rarely used. Patients with risk factors identified in this study should be monitored or given 
prophylaxis for VTE. 
 
Key Words: Inflammatory bowel disease; deep venous thrombosis; pediatric surgery; colectomy 












Inflammatory bowel disease (IBD) is a known risk factor for venous thromboembolism (VTE) in 
adults, and national guidelines exist that direct chemoprophylaxis in this population [1,2]. Pediatric 
patients with IBD have also been shown to have increased incidence of VTE (deep venous thrombosis, 
DVT or pulmonary embolism, PE), though the data is less robust [3,4]. A recent review of the Kids’ 
Inpatient Database demonstrated a 1% incidence of DVT in pediatric patients hospitalized with IBD, and 
the odds were twice as high for patients undergoing a major surgical procedure [4]. Similarly, in adult 
patients with IBD the risk of developing a VTE is as high as 2-3% following abdominal surgery.  
The American College of Gastroenterology recommends chemical VTE prophylaxis in adults 
admitted with acute severe ulcerative colitis (UC) or during disease flares [1]. Currently there are no 
consensus guidelines for VTE prophylaxis in the pediatric population, and practice varies. VTE 
prophylaxis recommendations have been published for pediatric trauma patients, which generally support 
chemical prophylaxis in patients deemed to be high risk due to factors such as central line placement, 
prolonged immobilization, traumatic brain injury, and high injury severity score [5-7]. Similarly, the 
Association of Paediatric Anaesthetists of Great Britain and Ireland recently published practice guidelines 
for perioperative VTE prevention in pediatric surgical patients [8]. Their risk score includes a number of 
patient- and admission-related factors associated with VTE, and recommends considering perioperative 
chemoprophylaxis if >2 factors are present and bleeding risk is low. While one risk factor listed is an 
underlying inflammatory condition, it does not specifically account for acute IBD flare occurring in the 
setting of intra-abdominal operation. 
Based on the paucity of relevant, patient-level data available to guide decision-making regarding 
VTE prophylaxis in pediatric patients undergoing surgery for IBD, we sought to determine the incidence 










wanted to evaluate current perioperative VTE prophylaxis practices and their impact on postoperative 
VTE rate. 
2. Methods 
2.1  Study design 
A retrospective review of patients who underwent major colorectal surgery for IBD at four 
tertiary care children’s hospitals was performed following IRB approval.  All patients ≤18 years of age 
who underwent colon or rectal resection (procedure name including colectomy, proctectomy, 
ileocecectomy, or ileal pouch-anal anastomosis) for a diagnosis of Crohn disease (CD), ulcerative colitis 
(UC), or indeterminate colitis (IC) between January 2010 and June 2016 were included in the study. 
Exclusion criteria were procedures limited to the small bowel and perianal procedures. Patients were 
identified using diagnostic and procedure codes at each institution and eligibility was confirmed via 
review of the medical record.  
2.2 Data collection 
Demographic data were collected that included patient age, sex, IBD diagnosis, and any history 
of hypercoagulable state such as smoking, current oral contraceptive (OCP) use, sickle cell disease, 
personal cancer history, personal history of VTE, and known thrombophilia. Preoperative characteristics 
included duration of IBD symptoms, days in the hospital prior to the procedure, presence of a central 
venous catheter (CVC), parenteral nutrition (PN) administration, laboratory values within 30 days of the 
operation (hemoglobin, albumin, c-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)), red 
blood cell (RBC) transfusion within 14 days prior to the operation, and current medical therapy for IBD 
(corticosteroids, biologic therapy, and/or immunologic therapy).  
Procedure type, acuity, operative time, perioperative blood product administration, and 
perioperative use of mechanical and/or chemical VTE prophylaxis were collected. Procedures were 
documented as laparoscopic (meaning all or a major portion of the operation was completed 










of interest included complications, hospital length of stay (LOS), intensive care unit (ICU) admission, and 
date of last known follow-up. The primary outcome was diagnosis of VTE (DVT or PE) at any point 
between surgery and last known follow-up. For those patients diagnosed with a postoperative VTE, 
pertinent details related to the diagnosis were also recorded including location of the thrombus, 
perioperative timing, whether the thrombus was symptomatic or diagnosed incidentally, association with 
a catheter or line, treatment, and time to resolution. 
2.3. Statistical Analysis 
Patient characteristics and outcomes were described through summary statistics, using median 
with interquartile range for continuous variables and frequency (%) for categorical variables. To analyze 
comparative data, Fisher’s exact test was used for categorical variables and Wilcoxon rank-sum for 
continuous variables. We used a priori knowledge regarding risk factors for VTE to create a model using 
multivariable time-dependent analysis (Cox regression). Variables with p-value <0.2 on univariable 
analysis were included in a Cox regression model to calculate the adjusted hazard ratio and 95% 
confidence interval for VTE diagnosis after colorectal surgery in IBD. As one institution was missing data 
for a number of significant variables, these patients were excluded from the regression analysis. Further, 
variables with missing data that significantly affected the number of VTEs included in the model or that 
demonstrated collinearity with other included variables were excluded from the regression analysis. The 
excluded factors were preoperative laboratory values (albumin, CRP, ESR, and hemoglobin) and 
perioperative transfusion of RBCs or platelets. A p-value of < 0.05 was considered significant.   
3. Results 
3.1. Demographics and preoperative characteristics 
A total of 276 patients were included in this study over a five-year period, with an overall 4.3% 
incidence of DVT diagnosed between the operation and date of last follow-up. There were no PEs 










age (median age 15 years, p = 0.23) or gender (54% female, p = 0.24) between those patients diagnosed 
with a DVT and those that were not (Table 1). Overall 134 patients (48.5%) had a diagnosis of UC, 125 
(45.3%) a diagnosis of CD, and 17 (6.2%) a diagnosis of indeterminate colitis (IC), and though there was 
a trend toward UC being associated with a higher risk of DVT it was not statistically significant (58.3% 
vs 48.1%, p = 0.12).  There were no differences in history of hypercoagulable state including smoking 
status, oral contraceptive use, known thrombophilia, or prior VTE, however the frequency of all of these 
factors combined was low (12%). Further, only one patient had a history of sickle cell disease and no 
patients had a personal history of cancer. Duration of disease was also not associated with the 
development of DVT (median duration 19.5 months, p = 0.28). Patients who received a preoperative RBC 
transfusion within 14 days of their operation did have a significantly higher incidence of postoperative 
DVT (50% vs 19.1%, p = 0.019). Preoperative length of stay (median 0 days, p  >0.99), presence of a 
CVC (28.2%, p = 0.75), and PN administration (26.8%, p = 0.74) were not associated with a higher 
incidence of DVT. A number of preoperative laboratory tests were included in the univariable analysis, 
though a large proportion of patients were missing some or all of these data. A lower preoperative 
albumin level (2.9 g/dL vs 3.6 g/dL, p = 0.049) along with higher CRP (54 mg/dL vs 5.6 mg/dL, p = 
0.003) and ESR (50 mm/hr vs 26 mm/hr, p = 0.005) were all associated with higher incidence of DVT. 
Preoperative hemoglobin level was not significantly associated with DVT risk (median 10.7 g/dL, p = 
0.1), nor was the use of any specific IBD medical therapy (55.8% on corticosteroids, 58.7% on biologic 
therapy, and 32.6% on immunologic therapy). 
3.2. Perioperative characteristics 
The most common surgical procedure was subtotal or total colectomy (43.5%), followed by 
ileocecectomy (35.1%), proctocolectomy or completion proctectomy with ileal pouch-anal anastomosis 
(IPAA; 14.2%), and partial colectomy with or without primary anastomosis (7.2%) (Table 2). Colectomy 
(subtotal or total) was associated with a significantly higher incidence of DVT compared to any of the 
other procedure types (75% vs 42.4%, p = 0.035). Further, operative acuity showed an association with 










DVT versus 4.2% of cases that did not (p = 0.002). Longer operative time showed a trend toward 
increased incidence of DVT, though it was not significant (431 min vs 278 min, p = 0.06). Operative 
technique (laparoscopic versus open) was not associated with a difference in DVT rates (83.7% of cases 
that did not develop DVT were performed laparoscopically vs 75% that did develop DVT; p = 0.43), 
though overall only 16.7% of cases were performed open. 
Only 88 patients (32.1%) had sequential compression devices (SCDs) placed perioperatively for 
mechanical VTE prophylaxis, and even fewer (42, 15.3%) received perioperative chemoprophylaxis. 
Prophylactic practices varied significantly between institutions, with rates of mechanical prophylaxis 
ranging from 0-76% and chemoprophylaxis ranging from 0-34% depending on institution. Neither 
mechanical nor chemical VTE prophylaxis were associated with development of DVT (p = 0.21 and 
>0.99, respectively), and due to the low frequencies and poor documentation we were unable to perform 
analyses based on timing of prophylaxis. There was no significant difference in postoperative bleeding 
complications in patients who received perioperative chemoprophylaxis versus those who did not (7.1% 
vs 2.6%, p = 0.15). Perioperative (intra- and post-operative) transfusion of RBCs was not associated with 
a higher incidence of DVT (14.5%, p = 0.39), though perioperative transfusions of plasma (16.7% vs 2%, 
p = 0.038) and platelets (16.7% vs 1%, p = 0.016) did show an association. Postoperatively, admission to 
the intensive care unit (4.2%, p = 0.08) and hospital length of stay (median 5 days, p = 0.74) were not 
significantly associated with development of DVT. The occurrence of any postoperative complication 
showed a strong association with increased incidence of DVT (75% vs 23.5%, p < 0.001). This was 
mostly due to the higher incidence of combined infectious complications including wound infection, 
intra-abdominal abscess, anastomotic leak, pneumonia, urinary tract infection, and sepsis in the DVT 
cohort (41.7% vs 9.8%, p = 0.001). The most common complication listed as “other” was postoperative 
ileus. 
3.3. Follow-up 
Median length of postoperative follow-up was 186 weeks, with a minimum of 11 days and 










multi-system organ failure. All other patients had at least one postoperative follow-up visit documented. 
Ninety-seven percent of patients had documented follow-up >60 days postoperatively.  
3.4. Multivariable time-dependent analysis 
 Cox regression was performed to further evaluate the factors associated with postoperative DVT. 
Following exclusion of one institution’s data as discussed in section 2.3, there were a total of 212 patients 
included in the regression analysis with 12 DVTs (5.7%). The variables selected for the regression were 
IBD diagnosis (UC, CD, or IC), OCP use, preoperative length of stay >1 day, preoperative RBC 
transfusion, colectomy (subtotal or total), emergent procedure, operative time >300 minutes, perioperative 
plasma transfusion, postoperative ICU admission, and occurrence of a postoperative infectious 
complication (Table 3). The factors that were found to significantly increase the risk of DVT on 
multivariable analysis were emergent procedure (HR 18.8, 95%CI: 3.18-111), perioperative plasma 
transfusion (HR 25.1, 95%CI: 2.4-259), and postoperative infectious complication (HR 10.5, 95%CI: 
2.63-41.8).  
3.5. DVT characteristics 
A total of 12 DVTs were diagnosed during the study period, and no PEs were identified (Table 
4). The most common DVT location was intra-abdominal (portomesenteric; 75%), followed by upper 
extremity (16.7%) and lower extremity (8.3%). All extremity DVTs were catheter-associated and 
symptomatic at diagnosis (3/3), while two-thirds of intra-abdominal DVTs were diagnosed incidentally 
(6/9). Median time from operation to diagnosis of a DVT was 14 days, with a range from four to 451 
days. Of the four DVTs diagnosed >60 days following their initial colectomy, the first was a portal vein 
thrombus that presented symptomatically one-week after staged IPAA, the second was a catheter-
associated basilic vein thrombus, and the remaining two were intra-abdominal DVTs that were diagnosed 
incidentally on imaging. Eleven of the 12 DVTs were treated with therapeutic anticoagulation, and 
median time to resolution was 5 weeks. One patient died while being treated for an intra-abdominal DVT 










On subgroup analysis of the patients found to have portomesenteric DVTs, 78% (7/9) underwent 
subtotal or total colectomy, 78% were performed laparoscopically, and the median operative time was 
455 minutes (IQR = 385-471 mins). In comparison to the patients that were diagnosed with extremity 
DVTs, there were no significant differences in procedure type (2/3; 67% subtotal or total colectomy), 
laparoscopic technique (67% laparoscopic), or operative time (median OR time = 359 mins; IQR = 140-
655 mins) compared to patients with portomesenteric DVTs (all p > 0.05). 
4. Discussion 
This study sought to identify risk factors associated with VTE specifically in pediatric patients 
who undergo colorectal resection for IBD. We found a 4.3% incidence of DVT in this multi-institutional 
cohort, the majority being incidentally found intra-abdominal thromboses. No PEs occurred during the 
study period. Multivariable regression analysis identified emergent procedure, perioperative plasma 
transfusion, and postoperative infectious complications as independent predictors of DVT. 
Inflammatory bowel disease is a known risk factor for VTE, with prior literature identifying a 
prevalence ratio of 1.8 in pediatric patients with IBD compared to other hospitalized children [9]. Further, 
children with IBD who undergo intra-abdominal operations are at even greater risk of thrombotic events 
[3,4]. Studies in adult patients have found that active disease flares increase the risk of VTE in IBD 
patients as well [1,2]. While we did not specifically assess for active disease in this study, it can be 
inferred by other variables such as preoperative LOS, preoperative RBC transfusion, inflammatory 
markers (CRP, ESR), and acuity of the procedure. A number of these variables were associated with 
postoperative DVT on univariable analysis, and emergent procedure was identified as an independent 
predictor on multivariable regression.  
There is a growing body of evidence noting the interaction between coagulation and 
inflammation, which is attributed to enhancement of the hypercoagulable state and increased endothelial 










associated with the development of VTE including CRP, IL-6, IL-8, and TNF-alpha. We found similar 
results in this study, as CRP and ESR levels were significantly higher in patients diagnosed with DVT. 
These laboratory tests are not routinely checked in all patients prior to surgery, however, so we were 
unable to include these markers in our regression analysis. Lending further weight to the association 
between active inflammation and VTE is the finding that postoperative infectious complications were 
predictive of DVT in our data. This association has been described previously in other patient populations 
including those with hematologic malignancies and osteomyelitis [11-13]. It is important to consider the 
level of active inflammation present when determining whether to prescribe mechanical or chemical VTE 
prophylaxis to IBD patients undergoing colorectal surgery. Further, the duration of the postoperative pro-
inflammatory, hypercoagulable state is not well-defined in children but has been shown to extend for up 
to two to six weeks in adults [14,15]. Our data found a median postoperative time of two weeks prior to 
DVT diagnosis, however there were a number of events that occurred much further out than that. Some 
adult literature discusses the potential benefits of extending postoperative chemoprophylaxis during this 
time, similarly to standard practice following colorectal surgery for cancer [15]. It is also important that 
gastroenterologists be aware of the increased risks that recent surgery and active inflammation have on 
the development of VTE in IBD patients as they will ultimately be responsible for following these 
patients long-term.  
Another interesting finding in this study was the association between perioperative plasma 
transfusion and DVT. It is pertinent to note that the number of patients who received a plasma transfusion 
was low (4 patients without DVT vs 2 patients with DVT), however it remained an independent predictor 
of DVT after regression analysis. There is prior data to suggest that blood transfusions are associated with 
increased risk of VTE in both adults and children [16,17]. Further, a study out of the adult trauma 
literature identified a 25% increase in VTE risk for each unit of fresh frozen plasma (FFP) transfused in 
patients who required less than four units of RBCs [18]. It is not uncommon for patients with active IBD 










intraoperatively necessitating transfusion of blood or coagulation factors. Yet these data would encourage 
physicians to be prudent in administering perioperative blood products to patients undergoing surgery for 
IBD, and to consider postoperative VTE prophylaxis in these patients as soon as is medically safe. 
Further, the American College of Gastroenterology recommends chemical prophylaxis with low-
molecular-weight heparin for adult patients in an acute flare even with active bleeding from their UC, as it 
has not been shown to worsen hemorrhage [1,19]. 
Though there are strong recommendations for chemical VTE prophylaxis in adult patients with 
IBD, this data is lacking in children. Our study found very low rates of both mechanical and chemical 
prophylaxis, and practice varied considerably by institution. For mechanical prophylaxis, a total of 32.1% 
of patients had SCDs placed in the operating room, and this percentage ranged from 0-76% depending on 
institution. Chemical prophylaxis was even less common, with overall 15.3% of patients receiving 
perioperative dosing which again ranged from 0-34% depending on institution. We found no significant 
differences in DVT rates or postoperative bleeding complications based on prophylaxis, however with 
such low utilization it is difficult to make any conclusions. Interestingly, a recent study utilizing the 
National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database did not find IBD to be an 
independent risk factor for VTE in general surgery patients undergoing abdominopelvic operations [20]. 
This is in contrast to a number of other large database studies in both the adult and pediatric literature that 
have demonstrated IBD to be independently predictive of VTE in both hospitalized patients and those 
undergoing colorectal resections [9,21,22]. While there were a number of limitations with the NSQIP-P 
study, including small sample size of IBD patients and no limitations on the type of abdominopelvic 
procedures included, another plausible reason for the lack of significance could be that overall VTE 
prophylaxis has become more commonplace in the surgical management of IBD and may be reflected in 
patient outcomes. 
A final note-worthy finding in our study was the high incidence of intra-abdominal DVTs. 










asymptomatic and found incidentally on imaging. Prior data has found that portomesenteric venous 
thrombosis (PMVT) is not uncommon following colorectal surgery for IBD, and that it is likely an under-
recognized complication [23]. Postoperative time to presentation is often weeks after discharge, and 
PMVT has been found to be associated with emergent operations and elevated CRP similar to our 
findings. Symptoms, when present, include abdominal pain, fever, and nausea/vomiting [24]. Our data 
found no correlation between PMVT and laparoscopic technique, which is similar to other findings in the 
literature [25,26]. There is conflicting data as to the morbidity associated with PMVT following colorectal 
surgery, though some small series have identified associated hepatic abscesses or at the extreme end of 
the spectrum septic thrombophlebitis of the portal vein [24,27]. Most studies recommend a course of 
therapeutic anticoagulation when PMVT is recognized so as to prevent further progression and poor 
outcomes. 
This retrospective multi-institutional study has several limitations.  The impact of laparoscopic 
pneumoperitoneum duration and pressure measurements is not collected in this dataset.  While four 
institutions contributed data, one institution had incomplete variables collected and so these patients could 
not be included in the multivariable regression model. This significantly affects the power of our 
statistical analyses. Further, we were unable to evaluate the effect of timing of VTE prophylaxis on 
postoperative DVT rate due to the low frequencies of both mechanical and chemical prophylaxis in our 
cohort. Sub-analysis of patients diagnosed with DVTs was also limited due to low sample sizes. Future 
prospective study with greater sample sizes is needed to further validate our results.    
Based on the findings of this study  in addition to documented rates of VTE in other cohorts 
evaluating pediatric IBD patients, we would recommend perioperative mechanical VTE prophylaxis in all 
patients undergoing abdominal surgery for IBD, and to consider chemical prophylaxis in this high-risk 
population on an individualized basis. Other risk factors for DVT identified here include emergent 
procedure, perioperative plasma transfusion, and postoperative infectious complications. We are unable to 










so low. As our study is limited by its retrospective nature, further prospectively collected data is needed to 
develop practice guidelines regarding VTE risk in pediatric patients undergoing colorectal resection for 
IBD. 
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Table 1. Patient demographics and preoperative 
characteristics. 
    
  Postoperative DVT  
 All (N = 276) No (N = 264) Yes (N = 12) p-value 
Age (years); median [IQR] 15 [13,17] 15 [13,17] 16 [15,17] 0.23
w 
Sex (% female) 149 (54%) 145 (54.9%) 4 (33.3%) 0.24
e 
IBD Diagnosis    0.12
e 
    UC 134 (48.5%) 127 (48.1%) 7 (58.3%)  
    CD 125 (45.3%) 122 (46.2%) 3 (25%)  
    IC 17 (6.2%) 15 (5.7%) 2 (16.7%)  
History of hypercoagulable state     
    Current or former smoker (N = 266) 6 (2.3%) 6 (2.4%) 0 >0.99
e 
    Current OCP use 17 (6.2%) 15 (5.7%) 2 (16.7%) 0.16
e 
    Known thrombophilia  5 (1.8%) 5 (1.9%) 0 >0.99
e 
    Prior VTE (N = 214) 5 (2.3%) 4 (2%) 1 (8.3%) 0.25
e 
Preoperative characteristics     
    Duration of disease (mos); median [IQR] 19.5 [7,48] 20 [8,48] 9 [2.5,54] 0.28
w 
    Preop LOS (days); median [IQR]  0 [0,5] 0 [0,5] 2.5 [1,5.5] 0.1
w 
    RBC transfusion within 14 days (N = 274) 56 (20.4%) 50 (19.1%) 6 (50%) 0.019
e 
    Presence of CVC 78 (28.2%) 74 (28%) 4 (33.3%) 0.75
e 
    PN administration  74 (26.8%) 70 (26.5%) 4 (33.3%) 0.74
e 
    Lab tests within 30 days; median [IQR]     
        Albumin (g/dL) (N = 161) 3.6 [2.9,4.1] 3.6 [2.9,4.1] 2.9 [2.8,3.2] 0.049
w 
        CRP (mg/dL) (N = 137) 5.8 [2.3,20.3] 5.6 [2.1,17.9] 54 [25,100] 0.003
w 
        ESR (mm/hr) (N = 129) 27 [15,50] 26 [14,49] 50 [45,78] 0.005
w 
        Hemoglobin (g/dL) (N = 204) 10.7 [9.5,12.3] 10.8 [9.5,12.3] 9.7 [8.7,11.1] 0.1
w 
    IBD medical therapy     
        Corticosteroids 154 (55.8%) 146 (55.3%) 8 (66.7%) 0.56
e 
        Biologic therapy 162 (58.7%) 156 (59.1%) 6 (50%) 0.56
e 
        Immunologic therapy 90 (32.6%) 87 (33%) 3 (25%) 0.76
e 
All numerical values documented in number (%) unless otherwise stated. 
Statistical tests: 
w
 Wilcoxon rank-sum, 
e
 Fisher's exact 
Abbreviations: DVT, deep venous thrombosis; IQR, interquartile range; IBD, inflammatory bowel disease; UC, 
ulcerative colitis; CD, Crohn disease; IC, indeterminate colitis; OCP, oral contraceptive; VTE, venous 
thromboembolism; LOS, length of stay; RBC, red blood cell; CVC, central venous catheter; PN, parenteral 












Table 2. Perioperative characteristics. 
  Postoperative DVT   
 All (N = 276) No (N = 264) Yes (N = 12) p-value 
Procedure type     
Colectomy (subtotal or total) 120 (43.5%) 111 (42.0%) 9 (75%) 0.035e 
Ileocecectomy 97 (35.1%) 95 (36%) 2 (16.7%)  
Proctocolectomy with IPAA 19 (6.9%) 19 (7.2%) 0  
Completion proctectomy with IPAA 20 (7.3%) 20 (7.6%) 0  
Partial colectomy with anastomosis 14 (5.0%) 13 (4.9%) 1 (8.3%)  
Partial colectomy with ostomy  6 (2.2%) 6 (2.3%) 0  
Acuity     
Emergent 15 (5.4%) 11 (4.2%) 4 (33.3%) 0.002e 
Urgent 108 (39.1%) 103 (39%) 5 (41.7%)  
Elective 153 (55.5%) 150 (56.8%) 3 (25%)  
Operative characteristics     
OR time (mins); median [IQR] (N = 214) 287 [180,407] 278 [180,401] 431 [255,520] 0.06w 
Operative technique     
Open 46 (16.7%) 43 (16.3%) 3 (25%) 0.43e0.43e 
Laparoscopic 230 (83.3%) 221 (83.7%) 9 (75%)  
Periop SCDs placed (N = 274) 88 (32.1%) 82 (31.3%) 6 (50%) 0.21e0.21e 
Periop VTE chemoprophylaxis (N = 274) 42 (15.3%) 40 (15.3%) 2 (16.7%) >0.99e>0.99e 
Periop RBC transfusion  40 (14.5%) 37 (14%) 3 (25%) 0.39e0.39e 
Periop plasma transfusion (N = 214) 6 (2.2%) 4 (2%) 2 (16.7%) 0.038e0.038e 
Periop platelet transfusion (N = 214) 4 (1.4%) 2 (1%) 2 (16.7%) 0.016e0.016e 
Postop ICU admission (N = 214) 9 (4.2%) 7 (3.5%) 2 (16.7%) 0.08e0.08e 
Postoperative complications    0.001e0.001e 
Wound infection/dehiscence 8 (11.4%) 8 (13.1%) 0  
Intra-abdominal abscess 6 (8.5%) 4 (6.6%) 2 (16.7%)  
Anastomotic leak 6 (8.6%) 6 (9.8%) 0  
Bowel obstruction requiring operation 7 (10%) 6 (9.9%) 1 (8.3%)  
Pneumonia 3 (4.3%) 2 (3.3%) 1 (8.3%)  
Sepsis 6 (8.5%) 5 (8.2%) 1 (8.3%)  
Bleeding complication 9 (12.9%) 8 (13.1%) 1 (8.3%)  
Urinary tract infection 2 (2.9%) 1 (1.6%) 1 (8.3%)  
Other 23 (32.9%) 21 (34.4%) 2 (16.8%)  
Postop LOS (days); median [IQR] 5 [4,7] 5 [4,7] 4.5 [3,9] 0.74w 
All numerical values documented in number (%) unless otherwise stated. 
Statistical tests: w Wilcoxon rank-sum, e Fisher's exact 
Abbreviations: DVT, deep venous thrombosis; IQR, interquartile range; IPAA, ileal pouch-anal anastomosis; OR, 
operating room; SCDs, sequential compression devices; VTE, venous thromboembolism; RBC, red blood cell; ICU, 












Table 3. Cox regression analysis of postoperative DVT. 
Independent variable HR St. Err. 95% CI p-value 
Diagnosis     
UC Ref.    
CD 4.5 6.98 (0.22, 93.2) 0.33 
IC 0.68 0.78 (0.07, 6.57) 0.74 
OCP use 3.37 2.98 (0.59, 19.1) 0.17 
Preoperative LOS >1 day 0.77 0.72 (0.12, 4.79) 0.78 
Preoperative RBC transfusion 3.59 3.71 (0.47, 27.2) 0.22 
Colectomy (subtotal or total) 8.21 12.9 (0.38, 178) 0.18 
Emergent procedure 18.8 17.1 (3.18, 111) 0.001 
OR time >300 mins 4.44 3.72 (0.86, 22.9) 0.08 
Perioperative plasma transfusion 25.1 29.9 (2.4, 259) 0.007 
Postoperative ICU admission 0.3 0.31 (0.04, 2.29) 0.24 
Postoperative infectious complication 10.5 7.4 (2.63, 41.8) 0.001 
Model χ2 = 36.58, p = 0.0001 
N (subjects) = 212, n (DVT) = 12 
Abbreviations: DVT, deep venous thrombosis; HR, hazard ratio; St. Err, standard error; CI, confidence interval; 
Ref., reference; UC, ulcerative colitis; CD, Crohn disease; IC, indeterminate colitis; OCP, oral contraceptives; LOS, 












Table 4. Postoperative DVT characteristics. 
Characteristic All DVTs (N = 12) 
Location  
Upper extremity 2 (16.7%) 
Lower extremity 1 (8.3%) 
Intra-abdominal (portomesenteric) 9 (75%) 
Symptomatic 6 (50%) 
Catheter-associated  3 (25%) 
Time from operation to diagnosis (days); 
median [IQR] 
14 [8,147] 
Treated with therapeutic anticoagulation 11 (91.7%) 
Time to resolution (weeks); median [IQR] 5 [4,12] 
All numerical values documented in number (%) unless otherwise stated. 
Abbreviations: DVT, deep venous thrombosis; IQR, interquartile range 
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